ES2160594T3 - Antigenos protectores contra la infeccion por echinococcus granulosus y vacunas que contienen estos antigenos. - Google Patents

Antigenos protectores contra la infeccion por echinococcus granulosus y vacunas que contienen estos antigenos.

Info

Publication number
ES2160594T3
ES2160594T3 ES93905659T ES93905659T ES2160594T3 ES 2160594 T3 ES2160594 T3 ES 2160594T3 ES 93905659 T ES93905659 T ES 93905659T ES 93905659 T ES93905659 T ES 93905659T ES 2160594 T3 ES2160594 T3 ES 2160594T3
Authority
ES
Spain
Prior art keywords
antigens
against infection
vaccines containing
echinococcus granulosus
protective
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93905659T
Other languages
English (en)
Inventor
David Duncan Heath
Stephen Bruce Lawrence
Mark John Ralston
David Richard Maass
Marshall William Lightowlers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Melbourne
AgResearch Ltd
Original Assignee
University of Melbourne
AgResearch Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Melbourne, AgResearch Ltd filed Critical University of Melbourne
Application granted granted Critical
Publication of ES2160594T3 publication Critical patent/ES2160594T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • C07K14/4355—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from cestodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

ESTA INVENCION SE REFIERE A POLIPEPTIDOS ANTIGENOS O FRAGMENTOS DE PEPTIDOS, O VARIANTES DE LOS MISMOS, ADECUADOS PARA USO EN VACUNAS QUE PROTEJAN HUESPEDES SUSCEPTIBLES DE INFECCION POR PARASITOS ECHINOCOCCUS O TAENLIDOS, EN ESPECIAL INFECCION DEBIDA A E. GRANULOSUS. LOS ANTIGENOS SE OBTIENEN PREFERENTEMENTE MEDIANTE EXPRESION DE CODIFICACION DEL DNA (CUALQUIERA DE LA CLASE DE ACIDOS NUCLEICOS QUE CONTIENEN DEOXIRRIBOSA) PARA ESTO, EN UNA CELULA HUESPED RECOMBINANTE. EL POLIPEPTIDO ANTIGENO DE LA INVENCION INCLUYE LA SECUENCIA AMINOACIDA DE LA FIGURA 4.
ES93905659T 1992-02-21 1993-02-22 Antigenos protectores contra la infeccion por echinococcus granulosus y vacunas que contienen estos antigenos. Expired - Lifetime ES2160594T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NZ24168892 1992-02-21

Publications (1)

Publication Number Publication Date
ES2160594T3 true ES2160594T3 (es) 2001-11-16

Family

ID=19923888

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93905659T Expired - Lifetime ES2160594T3 (es) 1992-02-21 1993-02-22 Antigenos protectores contra la infeccion por echinococcus granulosus y vacunas que contienen estos antigenos.

Country Status (12)

Country Link
EP (1) EP0629131B1 (es)
JP (1) JPH07504088A (es)
AU (1) AU676828B2 (es)
BG (1) BG61754B1 (es)
BR (1) BR9305933A (es)
DE (1) DE69330385T2 (es)
ES (1) ES2160594T3 (es)
HU (1) HU220575B1 (es)
PT (1) PT629131E (es)
RU (1) RU2205875C2 (es)
UA (1) UA45946C2 (es)
WO (1) WO1993016722A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1886936A1 (en) 2006-08-11 2008-02-13 Graphic Packaging International, Inc. Construct for heating a rounded food item in a microwave oven and blank therefore
CN109234410A (zh) * 2018-11-15 2019-01-18 海南国际旅行卫生保健中心（海南出入境检验检疫局口岸门诊部） 一种基于环介导等温扩增技术的检测包虫病的方法
CN113214374B (zh) * 2020-02-06 2022-08-26 深圳华大基因股份有限公司 一种包虫病新抗原Cystatin蛋白
CN113214373B (zh) * 2020-02-06 2022-08-30 深圳华大基因股份有限公司 新包虫病抗原Murinoglobulin-2蛋白
CN111796090B (zh) * 2020-04-21 2023-02-07 沈阳农业大学 牛细粒棘球蚴病时间分辨荧光免疫层析检测试纸条及其制备方法
CN112014556A (zh) * 2020-08-04 2020-12-01 中国农业科学院兰州兽医研究所 一种牛棘球蚴eg95蛋白抗体间接elisa检测试剂盒

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU642874B2 (en) * 1989-05-09 1993-11-04 Her Majesty The Queen In Right Of New Zealand Through The Ministry Of Agriculture And Fisheries Stable forms of antigenic taenia ovis polypeptides
FR2664613B1 (fr) * 1990-07-12 1994-08-26 Pasteur Institut Sequence peptidique immunogene d'echinococcus granulosus, sequence d'adn codant pour cette sequence peptidique et applications diagnostiques et therapeutiques.

Also Published As

Publication number Publication date
AU676828B2 (en) 1997-03-27
BG61754B1 (bg) 1998-05-29
PT629131E (pt) 2001-12-28
HU9402404D0 (en) 1994-10-28
DE69330385D1 (de) 2001-08-02
UA45946C2 (uk) 2002-05-15
BR9305933A (pt) 1997-08-26
BG98989A (bg) 1995-07-28
WO1993016722A1 (en) 1993-09-02
EP0629131A4 (en) 1995-11-29
EP0629131A1 (en) 1994-12-21
DE69330385T2 (de) 2002-06-06
HU220575B1 (hu) 2002-03-28
HUT69925A (en) 1995-09-28
RU94045154A (ru) 1996-11-10
EP0629131B1 (en) 2001-06-27
JPH07504088A (ja) 1995-05-11
RU2205875C2 (ru) 2003-06-10
AU3650093A (en) 1993-09-13

Similar Documents

Publication Publication Date Title
MX9204685A (es) Secuencia de adn que codifica una proteina superficial externa (ospa) o derivado de la misma composicion de vacuna qe comprende tal proteina.
MX9207113A (es) Fragmento de adn, peptido que comprende una proteina superficial ha de un virus de gripe a y vacuna que comprende tal peptido.
ES2059565T3 (es) Virus mva de la vacuna, recombinante.
ES2174856T3 (es) Proteinas de choque termico y tratamiento de tumores.
FI950405A0 (fi) Heikosti immunogeenisten antigeenien ja synteettisten peptidikantajien konjugaatit sekä niitä sisältävät rokotteet
HUP9901186A2 (hu) Peptid-és adjuvánsalapú gyógyszerkészítmény immunmodulációra
ES2167365T3 (es) Vectores adenovirales de origen animal y utilizacion en terapia genica.
AR003425A1 (es) Poxvirus recombinante de mapache, vacuna para uso en gatos y uso de poxvirus para preparar una vacuna util para evitar o para disminuir la enfermedad causada por el virus de inmunodeficiencia felina (fiv)
CO4480039A1 (es) Vacunas recombinantes de inmunodeficiencia felina producidas en baculovirus y su uso contra la infeccion de virus de inmunodeficiencia felina
FR2697022B1 (fr) Antigènes de Plasmodium falciparum capables d'induire des anticorps protecteurs à large spectre - Application à la vaccination.
DK0661999T3 (da) Vacciner mod felint immundefekt virus (FIV)
DE69328726D1 (de) Verwendung synthetischer peptide zur induktion der toleranz gegen t- und b-zell epitope von autoantigenen
ATE47524T1 (de) Hundeparvovirus-impfstoffe.
ES2115622T3 (es) Clones moleculares de hiv-1 y usos de los mismos.
ES2160594T3 (es) Antigenos protectores contra la infeccion por echinococcus granulosus y vacunas que contienen estos antigenos.
ES2146214T3 (es) Vacunas para actinobacillus pleuropneumoniae.
ES2137310T3 (es) Vacuna contra una infeccion por streptococcus suis.
ES2137160T3 (es) Lipopeptidos inductores de los linfocitos t-citotoxicos y utilizacion como vacunas.
DE68925660D1 (de) Peptidfragmente von HIV
ES2063383T3 (es) Vacunas contra la coccidiosis.
AR009365A1 (es) Vacunas del virus de la fiebre aftosa (fmdv), peptidos, secuencias de adn y el uso de los peptidos en sistemas de deteccion y el uso de la vacuna fmdc para la preparacion de una composicion para inmunizar cerdos y ganado vacuno
BR0206112A (pt) Vacinas de ácido nucléico usando ácidos nucléicos de codificação de antìgeno de tumor com ácido nucleìco de codificação de auxiliar de citocina
ATE234628T1 (de) Therapeutische anwendungen von antigenen oder epitopen assoziert mit unvollständiger zellulärer peptidprozesierung , z.b.: exprimiert in rma-s zellen transfiziert mit b7-1 gen
ES2118242T3 (es) Vacunas anti virus de la inmunodeficiencia felina (fiv).
NO964874L (no) Fusjonsglykoprotein fra HCMV og HSV

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 629131

Country of ref document: ES